Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 25 studies | 40% ± 14% | |
classical monocyte | 25 studies | 50% ± 13% | |
non-classical monocyte | 25 studies | 66% ± 16% | |
B cell | 23 studies | 26% ± 7% | |
monocyte | 21 studies | 49% ± 19% | |
conventional dendritic cell | 21 studies | 35% ± 9% | |
dendritic cell | 17 studies | 46% ± 16% | |
memory B cell | 16 studies | 28% ± 8% | |
neutrophil | 15 studies | 63% ± 25% | |
myeloid cell | 10 studies | 42% ± 17% | |
mast cell | 7 studies | 25% ± 4% | |
alveolar macrophage | 6 studies | 47% ± 14% | |
naive B cell | 5 studies | 23% ± 8% | |
mononuclear phagocyte | 5 studies | 45% ± 17% | |
leukocyte | 5 studies | 34% ± 13% | |
innate lymphoid cell | 4 studies | 28% ± 12% | |
intermediate monocyte | 4 studies | 63% ± 12% | |
monocyte-derived dendritic cell | 4 studies | 53% ± 17% | |
plasmacytoid dendritic cell | 3 studies | 25% ± 5% | |
CD4-positive, alpha-beta T cell | 3 studies | 17% ± 1% | |
germinal center B cell | 3 studies | 27% ± 6% | |
granulocyte | 3 studies | 28% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 2417.95 | 578 / 578 | 95% | 36.10 | 1097 / 1155 |
kidney | 45% | 107.61 | 40 / 89 | 69% | 12.48 | 623 / 901 |
intestine | 34% | 119.25 | 324 / 966 | 73% | 21.20 | 385 / 527 |
stomach | 23% | 81.35 | 81 / 359 | 80% | 24.43 | 230 / 286 |
breast | 34% | 99.16 | 158 / 459 | 68% | 19.80 | 762 / 1118 |
skin | 5% | 8.64 | 89 / 1809 | 95% | 155.94 | 449 / 472 |
lymph node | 0% | 0 | 0 / 0 | 100% | 479.11 | 29 / 29 |
peripheral blood | 100% | 5379.24 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 2362.90 | 241 / 241 | 0% | 0 | 0 / 0 |
thymus | 34% | 80.01 | 224 / 653 | 64% | 13.79 | 390 / 605 |
pancreas | 7% | 13.59 | 22 / 328 | 85% | 22.05 | 151 / 178 |
bladder | 24% | 690.76 | 5 / 21 | 64% | 17.81 | 321 / 504 |
tonsil | 0% | 0 | 0 / 0 | 87% | 39.77 | 39 / 45 |
esophagus | 11% | 28.30 | 160 / 1445 | 75% | 14.11 | 138 / 183 |
uterus | 12% | 40.97 | 20 / 170 | 73% | 15.73 | 335 / 459 |
liver | 55% | 175.85 | 124 / 226 | 28% | 4.80 | 113 / 406 |
adipose | 70% | 342.22 | 841 / 1204 | 0% | 0 | 0 / 0 |
ovary | 7% | 13.85 | 12 / 180 | 62% | 8.97 | 268 / 430 |
brain | 19% | 51.52 | 501 / 2642 | 48% | 13.75 | 341 / 705 |
prostate | 27% | 65.54 | 66 / 245 | 34% | 3.12 | 169 / 502 |
blood vessel | 28% | 99.98 | 372 / 1335 | 0% | 0 | 0 / 0 |
heart | 24% | 76.25 | 208 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 11% | 22.22 | 28 / 258 | 8% | 1.60 | 19 / 230 |
eye | 0% | 0 | 0 / 0 | 10% | 1.65 | 8 / 80 |
muscle | 2% | 3.18 | 20 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006919 | Biological process | activation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0008053 | Biological process | mitochondrial fusion |
GO_0097192 | Biological process | extrinsic apoptotic signaling pathway in absence of ligand |
GO_0008630 | Biological process | intrinsic apoptotic signaling pathway in response to DNA damage |
GO_0001836 | Biological process | release of cytochrome c from mitochondria |
GO_0055085 | Biological process | transmembrane transport |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0015267 | Molecular function | channel activity |
GO_0051400 | Molecular function | BH domain binding |
GO_0005515 | Molecular function | protein binding |
Gene name | BCL2A1 |
Protein name | Bcl-2-related protein A1 (Bcl-2-like protein 5) (Bcl2-L-5) (Hemopoietic-specific early response protein) (Protein BFL-1) (Protein GRS) BCL2 related protein A1 (cDNA FLJ60214, highly similar to Bcl-2-related protein A1) |
Synonyms | HBPA1 BCL2L5 BFL1 GRS |
Description | FUNCTION: Retards apoptosis induced by IL-3 deprivation. May function in the response of hemopoietic cells to external signals and in maintaining endothelial survival during infection (By similarity). Can inhibit apoptosis induced by serum starvation in the mammary epithelial cell line HC11 (By similarity). . |
Accessions | ENST00000335661.6 [Q16548-2] B4E1X9 Q16548 ENST00000677151.1 ENST00000267953.4 [Q16548-1] |